N-((S)-2-(5-((4-(((3S,4S)-3,4-dihydroxypyrrolidin-1-ylmethyl)phenyl)ethynyl)-1H-benzo[d][1,2,3]triazol-1-y1)-1-(methylthio)ethyl)-N-hydroxyformamide

ID: ALA4780225

Chembl Id: CHEMBL4780225

PubChem CID: 162662432

Max Phase: Preclinical

Molecular Formula: C22H23N5O4S

Molecular Weight: 453.52

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CS[C@@H](Cn1nnc2cc(C#Cc3ccc(N4C[C@H](O)[C@@H](O)C4)cc3)ccc21)N(O)C=O

Standard InChI:  InChI=1S/C22H23N5O4S/c1-32-22(27(31)14-28)13-26-19-9-6-16(10-18(19)23-24-26)3-2-15-4-7-17(8-5-15)25-11-20(29)21(30)12-25/h4-10,14,20-22,29-31H,11-13H2,1H3/t20-,21-,22-/m0/s1

Standard InChI Key:  HOWGEUFURVGLOQ-FKBYEOEOSA-N

Alternative Forms

  1. Parent:

    ALA4780225

    ---

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

lpxC UDP-3-O-acyl-GlcNAc deacetylase (700 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 453.52Molecular Weight (Monoisotopic): 453.1471AlogP: 0.91#Rotatable Bonds: 6
Polar Surface Area: 114.95Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 7.85CX Basic pKa: 0.83CX LogP: 2.18CX LogD: 2.05
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.17Np Likeness Score: -1.07

References

1. Furuya T,Shapiro AB,Comita-Prevoir J,Kuenstner EJ,Zhang J,Ribe SD,Chen A,Hines D,Moussa SH,Carter NM,Sylvester MA,Romero JAC,Vega CV,Sacco MD,Chen Y,O'Donnell JP,Durand-Reville TF,Miller AA,Tommasi RA.  (2020)  N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assay.,  28  (24): [PMID:33160146] [10.1016/j.bmc.2020.115826]

Source